BioQuad Life Sciences is recalling two lots of OsteoDenx dietary supplement capsules sold nationwide because the packages do not declare milk. People with a milk allergy or severe sensitivity could have a serious reaction, the company said in its Nov. 13 recall notice posted by the FDA. The company said it had received no reports of illness when it issued the notice.
Check the side panel of the carton
The same two lots apply to both the 30-capsule and 60-capsule cartons. Check the lot number and expiration date printed on the side panel:
- Lot 0524100, expires May 2027.
- Lot 0625041, expires August 2028.
The 30-capsule carton has UPC 857294007228. The 60-capsule carton has UPC 857294007341. The recall’s product photos show both carton sizes and the two lot stamps. The affected product was distributed from Nov. 1, 2024, through Nov. 11, 2026, through BioQuad’s website, Amazon, resellers and a dental clinic in Redwood City, California.
The company said the capsules contain lactoferrin from cow’s milk and that the problem came to light during an FDA inspection. The FDA lists milk as a major food allergen, and its labeling requirements also apply to dietary supplements.
Refunds and replacements
BioQuad says people who are allergic or sensitive to milk should stop taking the affected capsules and may discard them. Customers with either lot can request a full refund or a replacement in corrected packaging. Contact BioQuad at 714-660-1031, weekdays from 9:30 a.m. to 5 p.m. Pacific, or email service@bioquad.com. The company says it answers weekend and after-hours emails the next business day.
